Preoperative Antimicrobial Administration for Prevention of Postoperative Infection in Patients with Laparoscopic Cholecystectomy

Digestive Diseases and Sciences

Volumn 48, Issue 10, 2003, Pages 1955-1959

  Uchiyama, Kazuhisa ^a   Kawai, Manabu ^a   Onishi, Hironobu ^a   Tani, Masaji ^a   Kinoshita, Hiroyuki ^a   Ueno, Masaki ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

lactamase; Antimicrobial prophylaxis; Biliary infection; Laparoscopic cholecystectomy; Surgical site infection

Indexed keywords

ANTIINFECTIVE AGENT; CEFOPERAZONE; SULBACTAM; SULPERAZON;

ABDOMINAL ABSCESS; ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; CHOLECYSTECTOMY; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; FEVER; GALLBLADDER; HUMAN; INFECTION; INFECTION PREVENTION; KLEBSIELLA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; URINARY TRACT INFECTION; WOUND INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIA; BILE; CEFOPERAZONE; CHOLECYSTECTOMY, LAPAROSCOPIC; FEMALE; GALLBLADDER; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; SULBACTAM; SURGICAL WOUND INFECTION;

EID: 0242403484     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026114203622     Document Type: Article

References (14)

1. Sanchez-Ubeda R, Fernand E, Rousselot LM: Complication rate in general surgical cases: the value of penicillin and streptomycin as postoperative prophylaxis - a study of 511 cases. N Engl J Med 259:1045-1050, 1958
2. Page CP, Bohnen JM, Fletcher JR, McManus AT, Solomkin JS, Wittmann DH: Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg 128:78-88, 1993
3. Stewart L, Ponce R, Oesterle AL, Griffiss JM, Way LW: Pigment gallstone pathogenesis: slime production by biliary bacteria is more important than beta-glucuronidase production. J Gastrointest Surg 4:547-553, 2000
4. Sandstad O, Osnes T, Skar, V, Urdal P, Osnes M: Structure and composition of common bile duct stones in relation to duodenal diverticula, gastric resection, cholecystoctomy and infection. Digestion 61:181-188, 2000
5. Simmons BP: Guideline for prevention of surgical wound infections. Infect Control 3:185-196, 1982
6. Garner JS: Guideline for prevention of surgical wound infections, 1985. Infect Control 7:193-200, 1986
7. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR: Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 20:247-278, 1999
8. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP: The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 326:281-286, 1992
9. Lippert H, Gastinger J: Antimicrobial prophylaxis in laparoscopic and conventional cholecystectomy. Conclusions of a large prospective multicenter quality assurance study in Germany. Chemotherapy 44:355-363, 1998
10. Orda R, Berger SA, Levy Y, Shnaker A, Gorea A: Penetration of ceftriaxone and cefoperazone into bile and gallbladder tissue in patients with acute cholecystitis. Dig Dis Sci 37:1691-1693, 1992
11. Farello GA, Cerofolini A: Antimicrobial prophylaxis with ceftriaxone in laparoscopic cholecystectomy: a 7-year clinical experience involving 3,603 patients. J Chemother 12(suppl 3): 17-22, 2000
12. Winston DJ, Bartoni K, Bruckner DA, Schiller GJ, Territo MC: Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients. Clin Infect Dis 26:576-583, 1998
13. Leung JW, Chan RC, Cheung SW, Sung JY, Chung SC, French GL: The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime. J Antimicrob Chemother 25:399-406, 1990
14. Li JT, Lu Y, Hou J, Chen YF, Miao JZ, Jia YX, Hou J, Zhang XZ, Chen DK, Hu WZ, Li LJ, Liu DM, Wang Z, Wu J, Gu JM, Wang HL, Zhang YL, Sun L: Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial. Clin Infect Dis 24:498-505, 1997